Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (621-630 of 1,095) with videos related to

Pageof 110
Sort By:
Immunotherapy|June 9, 2018
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumabFrancesco Facchinetti, Michele Veneziani, Sebastiano Buti, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyPietro Lampertico, Thomas Berg, Maria Buti, et al.
World Journal of Gastroenterology|October 15, 2013
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from ArgentinaNoemí del Pino, José Raúl Oubiña, Francisco Rodríguez-Frías, et al.
Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Gastroenterology|September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis BEdward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
European Journal of Gastroenterology & Hepatology|May 4, 2016
Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b studyStefan Zeuzem, Parvez Mantry, Vicente Soriano, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trialsMaria Buti, David K Wong, Edward Gane, et al.
Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.
World Journal of Gastroenterology|December 7, 2016
New real-time-PCR method to identify single point mutations in hepatitis C virusQian Chen, Irene Belmonte, Maria Buti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2014
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of EgyptDorothée Obach, Sylvie Deuffic-Burban, Gamal Esmat, et al.
Pageof 110

Showing results (621-630 of 1,095) with videos related to

Sort By:
Pageof 110
Immunotherapy|June 9, 2018
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumabFrancesco Facchinetti, Michele Veneziani, Sebastiano Buti, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyPietro Lampertico, Thomas Berg, Maria Buti, et al.
World Journal of Gastroenterology|October 15, 2013
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from ArgentinaNoemí del Pino, José Raúl Oubiña, Francisco Rodríguez-Frías, et al.
Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Gastroenterology|September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis BEdward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
European Journal of Gastroenterology & Hepatology|May 4, 2016
Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b studyStefan Zeuzem, Parvez Mantry, Vicente Soriano, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trialsMaria Buti, David K Wong, Edward Gane, et al.
Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.
World Journal of Gastroenterology|December 7, 2016
New real-time-PCR method to identify single point mutations in hepatitis C virusQian Chen, Irene Belmonte, Maria Buti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2014
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of EgyptDorothée Obach, Sylvie Deuffic-Burban, Gamal Esmat, et al.
Pageof 110